The ability of mRNA vaccines to stimulate a robust and specific immune response against cancer cells offers hope for patients with various types of cancer. While further research is needed to optimise these vaccines and assess their long-term efficacy and safety, the early findings are encouraging. As research advances and clinical trials progress, we may soon witness the transformative impact of mRNA vaccines in the fight against this devastating disease.
PUBLISHED IN News in Review: DECEMBER 2024
The European Parliament’s Regulation (EU) 2017/745 on medical devices (MDR)[1] is a new set of regulations that governs the production and distribution of medical devices within the European Union (EU).
PUBLISHED IN News in Review: APRIL 2024
Clinical strength in digital health is gaining pace, which augurs well for adoption and complementing traditional clinical interventions and diagnostics.
PUBLISHED IN News in Review: APRIL 2024
Researchers are finding new uses for CAR-T therapy, with potential to treat not just cancer but also autoimmune diseases and viral infections such as HIV.
PUBLISHED IN News in Review: APRIL 2024